Your browser is no longer supported. Please, upgrade your browser.
Settings
OMCL Omnicell, Inc. daily Stock Chart
OMCL [NASD]
Omnicell, Inc.
Index- P/E- EPS (ttm)-0.27 Insider Own3.10% Shs Outstand36.84M Perf Week2.70%
Market Cap1.61B Forward P/E21.37 EPS next Y2.05 Insider Trans-10.90% Shs Float36.43M Perf Month6.57%
Income-9.80M PEG- EPS next Q0.23 Inst Own93.60% Short Float10.21% Perf Quarter9.36%
Sales672.20M P/S2.40 EPS this Y-98.00% Inst Trans11.01% Short Ratio15.96 Perf Half Y28.07%
Book/sh11.91 P/B3.68 EPS next Y60.03% ROA-1.10% Target Price45.75 Perf Year30.47%
Cash/sh1.26 P/C34.85 EPS next 5Y16.50% ROE-2.30% 52W Range30.35 - 44.60 Perf YTD29.20%
Dividend- P/FCF123.17 EPS past 5Y-44.30% ROI1.30% 52W High-1.79% Beta0.65
Dividend %- Quick Ratio1.10 Sales past 5Y23.00% Gross Margin44.30% 52W Low44.32% ATR0.84
Employees2444 Current Ratio1.50 Sales Q/Q-11.90% Oper. Margin-1.90% RSI (14)59.64 Volatility1.78% 2.08%
OptionableYes Debt/Eq0.49 EPS Q/Q- Profit Margin-1.50% Rel Volume0.82 Prev Close44.20
ShortableYes LT Debt/Eq0.47 EarningsAug 03 BMO Payout- Avg Volume233.08K Price43.80
Recom2.10 SMA202.89% SMA505.27% SMA20016.79% Volume190,321 Change-0.90%
Apr-21-17Downgrade Piper Jaffray Overweight → Neutral
Jan-19-17Initiated Dougherty & Company Buy $44
Dec-06-16Reiterated The Benchmark Company Buy $39 → $55
Jul-07-16Reiterated FBR Capital Outperform $35 → $40
Mar-21-16Reiterated Topeka Capital Markets Buy $38 → $37
Jan-07-16Initiated The Benchmark Company Buy $33
Nov-16-15Reiterated Topeka Capital Markets Buy $40 → $38
Oct-30-15Reiterated FBR Capital Outperform $40 → $35
Sep-28-15Upgrade Sidoti Neutral → Buy
Jul-31-15Reiterated Topeka Capital Markets Buy $39 → $40
Jul-31-15Reiterated Oppenheimer Outperform $44 → $42
Jun-18-15Initiated Oppenheimer Outperform $44
May-01-15Reiterated Topeka Capital Markets Buy $36 → $39
May-01-15Reiterated FBR Capital Outperform $35 → $40
Aug-28-14Reiterated Topeka Capital Markets Buy $30 → $31
Jun-13-14Initiated Topeka Capital Markets Buy $30
Mar-05-14Reiterated Laidlaw Buy $29 → $34
Jan-28-14Reiterated Laidlaw Buy $27 → $29
Oct-31-13Initiated FBR Capital Outperform $28
Feb-01-13Reiterated The Benchmark Company Buy $19 → $21
Jun-27-17 03:30PM  ETFs with exposure to Omnicell, Inc. : June 27, 2017 Capital Cube
Jun-26-17 02:45PM  Omnicell, Inc. :OMCL-US: Earnings Analysis: Q1, 2017 By the Numbers : June 26, 2017 Capital Cube
Jun-12-17 08:00AM  CompleteRx Partners with Omnicell to Support the Commonwealth of Massachusetts State Office of Pharmacy Services PR Newswire
Jun-09-17 06:53AM  Why Is Omnicell (OMCL) Up 3.3% Since the Last Earnings Report? Zacks
Jun-08-17 08:00AM  MACH4 Pharma Systems Receives German Global Health Award for South Africa Pharmacy Access Initiative PR Newswire
Jun-02-17 08:59AM  Omnicell, Inc. breached its 50 day moving average in a Bullish Manner : OMCL-US : June 2, 2017 Capital Cube
Jun-01-17 08:00AM  Omnicell Showcases Portfolio of Award-Winning Medication Management Solutions at Annual ASHP Summer Meeting PR Newswire
May-22-17 02:38PM  Omnicell, Inc. Value Analysis (NASDAQ:OMCL) : May 22, 2017 Capital Cube
May-19-17 08:20AM  Omnicell, Inc. breached its 50 day moving average in a Bullish Manner : OMCL-US : May 19, 2017 Capital Cube
May-18-17 08:05PM  Edited Transcript of OMCL earnings conference call or presentation 4-May-17 12:30pm GMT Thomson Reuters StreetEvents
May-09-17 08:00AM  Omnicell Adds to Product Offerings in Canada Through Agreement with McKesson Canada PR Newswire
08:00AM  Omnicell Adds to Product Offerings in Canada Through Agreement with McKesson Canada CNW Group
May-08-17 09:24AM  Edited Transcript of OMCL earnings conference call or presentation 4-May-17 12:30pm GMT Thomson Reuters StreetEvents
May-05-17 08:29AM  Omnicell (OMCL) Q1 Loss Narrower than Expected, Revenues Lag Zacks
May-04-17 09:16AM  Omnicell reports 1Q loss Associated Press -5.47%
08:00AM  Omnicell Announces First Quarter 2017 Results PR Newswire
07:30AM  Investor Network: Omnicell, Inc. to Host Earnings Call Accesswire
May-02-17 08:00AM  Southcoast Health Selects Omnicell's Medication Management and Analytics Solutions for Installation Across Multiple Facilities PR Newswire
May-01-17 08:00AM  Omnicell Announces Launch of XT Cabinets for AcuDose-Rx Customers PR Newswire
Apr-27-17 04:01PM  Omnicell to Release First Quarter 2017 Earnings Results on May 4, 2017 PR Newswire
Apr-25-17 08:00AM  North Memorial Health Selects Omnicell's Medication Management Solutions to Support Increased Safety and Efficiency Throughout the Hospital PR Newswire
Apr-19-17 08:00AM  Omnicell Acquires InPharmics PR Newswire
Apr-12-17 04:15PM  Omnicell Medication Adherence Named a 50+ Innovation Leader PR Newswire
Apr-07-17 09:15AM  Omnicell's Aesynt Buyout Looks Promising amid Several Woes Zacks
Mar-22-17 08:00AM  Omnicell's Newest Automated Dispensing Solutions to Be Showcased at the European Association of Hospital Pharmacists Congress PR Newswire
Mar-21-17 04:20AM  Why Is Omnicell (OMCL) Up 3% Since the Last Earnings Report? Zacks
Mar-20-17 08:00AM  Omnicell Supports Pharmacy Advancement through Unrestricted Grant PR Newswire
Mar-04-17 01:04PM  OMNICELL, INC Financials
Mar-02-17 08:25AM  RBC Says These Top Health Care Stocks Could Be 2017 Takeover Candidates 24/7 Wall St.
08:15AM  Post Earnings Coverage as WebMD Net Income Surged 32%; Revenue Gained 8% Accesswire
Feb-28-17 07:39PM  OMNICELL, INC Files SEC form 10-K, Annual Report
Feb-24-17 07:17AM  Omnicell: Q4 Report Disappoints, Aesynt Buyout Holds Promise Zacks
Feb-22-17 02:04PM  Omnicell, Inc. :OMCL-US: Earnings Analysis: 2016 By the Numbers : February 22, 2017 Capital Cube
02:04PM  Omnicell, Inc. :OMCL-US: Earnings Analysis: 2016 By the Numbers : February 22, 2017
Feb-21-17 11:45AM  Omnicell, Inc. :OMCL-US: Earnings Analysis: Q4, 2016 By the Numbers : February 21, 2017
08:00AM  Inova Partners with Omnicell to Enhance Pharmacy Supply Chain Strategy PR Newswire
Feb-16-17 09:04AM  Omnicell (OMCL) Q4 Earnings Deteriorate Y/Y, Revenues Miss Zacks
Feb-15-17 11:20PM  Edited Transcript of OMCL earnings conference call or presentation 15-Feb-17 9:30pm GMT
05:36PM  Omnicell misses Street 4Q forecasts AP
04:25PM  OMNICELL, INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities
04:01PM  Omnicell Reports Results for Fiscal Year and Fourth Quarter 2016 PR Newswire
07:07AM  Q4 2016 Omnicell Inc Earnings Release - After Market Close
Feb-14-17 08:12AM  Omnicell Partners with DCH Health for Sterile Compounding
08:00AM  Omnicell Launches Innovative Medication Adherence Automated Pharmacy Solution to Increase Pharmacy Efficiency and Profitability PR Newswire
Feb-13-17 04:26PM  OMNICELL, INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
04:01PM  Omnicell Medication Management Solutions and Interoperability Featured at HIMSS17 with Real World Application in Interoperability Showcase PR Newswire
08:00AM  DCH Health System Partners with Omnicell to Automate Sterile Compounding with Robotic IV Insourcing Solution (RIIS) PR Newswire
Feb-02-17 08:00AM  Omnicell to Release Fourth Quarter 2016 Earnings Results on February 15th PR Newswire
Jan-24-17 08:00AM  WellStar Health System Selects Omnicell's Medication Management Solutions to Promote EHR Interoperability and Medication Security PR Newswire
Jan-20-17 07:11AM  Omnicell, Inc. breached its 50 day moving average in a Bullish Manner : OMCL-US : January 20, 2017
Jan-19-17 06:15AM  Coverage initiated on Omnicell by Dougherty & Company
Jan-04-17 04:01PM  Omnicell To Present At The 35th Annual J.P. Morgan Healthcare Conference PR Newswire
Jan-03-17 07:10AM  Omnicell, Inc. breached its 50 day moving average in a Bullish Manner : OMCL-US : January 3, 2017
Dec-23-16 07:36AM  Omnicell, Inc. breached its 50 day moving average in a Bearish Manner : OMCL-US : December 23, 2016
Dec-20-16 02:51PM  Is Omnicell, Inc. (OMCL) a Good Stock to Buy? at Insider Monkey
Dec-14-16 11:01AM  Omnicell, Inc. Value Analysis (NASDAQ:OMCL) : December 14, 2016 -5.07%
08:00AM  Omnicell Completes Acquisition of Ateb, Inc. PR Newswire
Dec-13-16 07:13AM  Omnicell, Inc. breached its 50 day moving average in a Bullish Manner : OMCL-US : December 13, 2016
Dec-08-16 05:18PM  OMNICELL, INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial
09:09AM  San Francisco Bays biggest digital health company grows here, picks up Publix business at bizjournals.com
Dec-06-16 07:58AM  Omnicell Unveils XT Series Automated Dispensing System -6.26%
06:04AM  OMNICELL, INC Files SEC form 8-K, Regulation FD Disclosure
Dec-05-16 08:00AM  Omnicell Unveils New XT Series Automated Dispensing System at ASHP Mid-Year PR Newswire -5.76%
Dec-02-16 07:40AM  Omnicell to Buy Ateb, Expand in Adherence Tools Market
Dec-01-16 08:00AM  Omnicell Showcases Expanded Portfolio of Award-Winning Medication Management Solutions at Annual ASHP Midyear Meeting PR Newswire
Nov-30-16 05:55PM  B. Braun Announces Interoperability Collaboration with Omnicell's(R) Performance Center and IV AutomationTechnology Marketwired
04:01PM  Omnicell's Performance Center Integrates with Hospira's Infusion Pump Software PR Newswire
Nov-29-16 02:17PM  ETFs with exposure to Omnicell, Inc. : November 29, 2016
08:31AM  OMNICELL, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Sta
08:00AM  Omnicell to Acquire Leading Pharmacy Provider Ateb, Inc. PR Newswire
Nov-28-16 08:00AM  Omnicell Announces Analyst And Investor Briefing At The Annual ASHP Midyear Meeting PR Newswire
07:17AM  Omnicell, Inc. breached its 50 day moving average in a Bullish Manner : OMCL-US : November 28, 2016
Nov-21-16 08:00AM  Omnicell To Present At The 28th Annual Piper Jaffray Health Care Conference PR Newswire
Nov-16-16 04:01PM  Omnicell's OmniRx Automated Medication Dispensing System Receives Top KLAS Award for the 11th Consecutive Year PR Newswire
Nov-07-16 04:35PM  OMNICELL, INC Files SEC form 10-Q, Quarterly Report
Nov-02-16 09:29AM  Health Systems to Realize Improved Financial and Clinical Outcomes through Omnicell Performance Center PR Newswire
Oct-31-16 09:46AM  Omnicell (OMCL) Q3 Earnings Top, Revenues Miss Estimates
Oct-28-16 03:08PM  Edited Transcript of OMCL earnings conference call or presentation 27-Oct-16 8:30pm GMT -6.32%
Oct-27-16 06:05PM  Omnicell meets 3Q profit forecasts
04:12PM  OMNICELL, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:01PM  Omnicell Achieves Record Revenue in the Third Quarter 2016 PR Newswire
08:00AM  Wellforce Selects Omnicell's Medication Management Automation and Diversion Prevention Solutions PR Newswire
07:07AM  Q3 2016 Omnicell Inc Earnings Release - After Market Close
Oct-26-16 04:01PM  Leading Academic Medical Centers Upgrade Medication Management Technology to Increase Patient Safety and Promote Innovation PR Newswire
Oct-21-16 05:05PM  Omnicell to Release Third Quarter 2016 Earnings Results on October 27th PR Newswire
Oct-07-16 04:23PM  OMNICELL, INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events
Oct-03-16 12:25PM  Omnicell, Inc. Value Analysis (NASDAQ:OMCL) : October 3, 2016
Sep-30-16 08:24AM  Omnicell, Inc. breached its 50 day moving average in a Bearish Manner : OMCL-US : September 30, 2016
Sep-03-16 12:01AM  [$$] Investing From the Ground Up at Barrons.com
Aug-31-16 11:41AM  ETFs with exposure to Omnicell, Inc. : August 31, 2016
Aug-29-16 10:02AM  Omnicell, Inc. (Nasdaq: OMCL) to Ring The Nasdaq Stock Market Opening Bell GlobeNewswire
Aug-05-16 04:05PM  OMNICELL, INC Files SEC form 8-K, Other Events
Aug-03-16 01:38PM  Omnicell, Inc. :OMCL-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016
Aug-02-16 04:36PM  Omnicell (OMCL) Tops Q2 Earnings & Revenues, Margins Drag
Jul-29-16 12:22PM  Edited Transcript of OMCL earnings conference call or presentation 28-Jul-16 8:30pm GMT +6.79%
Jul-28-16 05:55PM  Omnicell reports 2Q loss AP
04:11PM  Omnicell Selected to Provide Interoperable Medication Automation Solutions to Support Patient Safety at Rochester Regional Health PR Newswire
04:10PM  OMNICELL, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:01PM  Omnicell Achieves Record Revenue in the Second Quarter 2016 PR Newswire
07:07AM  Q2 2016 Omnicell Inc Earnings Release - After Market Close
Omnicell, Inc. provides automation and business analytics software solutions for medication and supply management in healthcare worldwide. The company operates through two segments, Automation and Analytics, and Medication Adherence. It offers Omnicell Automated Dispensing Cabinets, a dispensing system, which automates the management and dispensing of medications; SinglePointe, a software product that controls medications; AnywhereRN, which remotely queue medications from automated dispensing cabinets; Omnicell Analytics and Pandora Analytics reporting and data analytics tools; and Savvy Mobile Medication Workstation, which provides a platform for hospital information systems. The company also provides OmniLinkRx, a prescription routing system; WorkflowRx, an automated pharmacy storage, retrieval, and packaging system; Central and Satellite Pharmacy Manager, an automated pharmacy storage and retrieval system; Controlled Substance Management, a controlled substance inventory management system; and Anesthesia Workstation that manages anesthesia supplies and medications. In addition, it offers Omnicell Supply Management System, which automates the management and dispensing of medical and surgical supplies; Omnicell Tissue Center, which manages the chain of custody for bone and tissue specimens; OptiFlex MS that manages medical and surgical supplies; OptiFlex SS, a module for the perioperative areas; OptiFlex CL, a module for the cardiac catheterization lab and other procedure areas. Further, Omnicell, Inc. offers Mach4 Pharma Systems Medimat, a robotic dispensing system for handling the stocking and retrieval of medications; IV Solutions; software; and consumable medication blister cards, packaging equipment, and ancillary products and services to institutional pharmacies. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was founded in 1992 and is headquartered in Mountain View, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LIPPS RANDALL AChairman, President, and CEOJun 19Sale42.8731,5271,351,657361,701Jun 20 11:12 AM
LIPPS RANDALL AChairman, President, and CEOJun 13Option Exercise0.0032,6000241,582Jun 15 06:09 PM
LIPPS RANDALL AChairman, President, and CEOJun 13Sale43.0032,6001,401,800208,982Jun 15 06:09 PM
LIPPS RANDALL AChairman, President, and CEOJun 05Option Exercise0.009,9000218,882Jun 06 05:50 PM
LIPPS RANDALL AChairman, President, and CEOJun 05Sale43.009,900425,700208,982Jun 06 05:50 PM
Judson James TDirectorMay 26Option Exercise0.006,733025,863May 26 05:20 PM
Judson James TDirectorMay 26Sale41.406,733278,77019,130May 26 05:20 PM
Judson James TDirectorMay 25Option Exercise0.005,415024,545May 26 05:20 PM
PETERSMEYER GARY SDirectorMay 25Sale41.412,20091,09718,875May 26 05:20 PM
Judson James TDirectorMay 25Sale41.625,415225,35319,130May 26 05:20 PM
JOHNSTON DAN SEVP-Chief Legal & Admin OffMay 19Option Exercise0.008,400070,096May 19 06:41 PM
JOHNSTON DAN SEVP-Chief Legal & Admin OffMay 19Sale40.6716,400666,98853,696May 19 06:41 PM
DREW J CHRISTOPHERExe VP, Sales & MarketingMay 09Sale40.9710,625435,308142,407May 09 05:40 PM
LIPPS RANDALL AChairman, President, and CEOApr 25Option Exercise0.0018,2000227,182Apr 26 11:23 AM
LIPPS RANDALL AChairman, President, and CEOApr 25Sale41.0018,200746,200208,982Apr 26 11:23 AM
PETERSMEYER GARY SDirectorMar 10Sale37.452,65899,54217,427Mar 10 05:28 PM
WHITE SARA JDirectorFeb 21Option Exercise0.003,443046,657Feb 21 06:41 PM
WHITE SARA JDirectorFeb 21Sale38.063,443131,02343,214Feb 21 06:41 PM
PETERSMEYER GARY SDirectorDec 14Option Exercise0.002,600020,085Dec 14 06:18 PM
JOHNSTON DAN SEVP-Chief Legal & Admin OffNov 18Option Exercise0.002,850055,727Nov 18 06:36 PM
JOHNSTON DAN SEVP-Chief Legal & Admin OffNov 18Sale33.658,850297,79252,877Nov 18 06:36 PM
Taborga Jorge R.Executive VP. EngineeringNov 18Sale33.662,06869,60045,155Nov 18 06:36 PM
DREW J CHRISTOPHERExe VP, Sales & MarketingNov 08Option Exercise0.0020,0000159,844Nov 08 07:17 PM
DREW J CHRISTOPHERExe VP, Sales & MarketingNov 08Sale31.9520,000638,994139,844Nov 08 07:17 PM
PETERSMEYER GARY SDirectorSep 12Option Exercise0.002,000019,987Sep 13 07:29 PM
PETERSMEYER GARY SDirectorSep 12Sale37.982,00075,95017,987Sep 13 07:29 PM
PETERSMEYER GARY SDirectorSep 08Option Exercise0.002,400020,387Sep 09 06:00 PM
PETERSMEYER GARY SDirectorSep 08Sale39.392,40094,52817,987Sep 09 06:00 PM
PETERSMEYER GARY SDirectorSep 06Sale39.022,00078,04717,987Sep 06 06:00 PM
PETERSMEYER GARY SDirectorSep 02Option Exercise0.002,000021,987Sep 02 07:03 PM
PETERSMEYER GARY SDirectorSep 02Sale38.702,00077,39019,987Sep 02 07:03 PM
PETERSMEYER GARY SDirectorSep 01Option Exercise0.001,000020,987Sep 02 07:03 PM
PETERSMEYER GARY SDirectorSep 01Sale38.181,00038,17519,987Sep 02 07:03 PM
JOHNSTON DAN SEVP-Chief Legal & Admin OffAug 19Option Exercise0.002,850061,727Aug 22 05:14 PM
Taborga Jorge R.Executive VP. EngineeringAug 19Sale36.921,77865,63847,295Aug 22 05:16 PM
JOHNSTON DAN SEVP-Chief Legal & Admin OffAug 19Sale36.938,850326,86058,877Aug 22 05:14 PM
LIPPS RANDALL AChairman, President, and CEOAug 11Sale37.351,16543,518154,900Aug 11 07:16 PM
LIPPS RANDALL AChairman, President, and CEOAug 10Sale37.3736,2601,354,978156,065Aug 11 07:16 PM
Judson James TDirectorAug 09Option Exercise0.006,250021,550Aug 09 07:17 PM
DREW J CHRISTOPHERExe VP, Sales & MarketingAug 09Option Exercise0.0015,0000154,844Aug 09 07:18 PM
Judson James TDirectorAug 09Sale37.986,250237,38715,300Aug 09 07:17 PM
DREW J CHRISTOPHERExe VP, Sales & MarketingAug 09Sale37.8915,000568,395139,844Aug 09 07:18 PM
PETERSMEYER GARY SDirectorAug 04Option Exercise0.007,050027,037Aug 05 05:45 PM
PETERSMEYER GARY SDirectorAug 04Sale37.847,050266,77219,987Aug 05 05:45 PM
PETERSMEYER GARY SDirectorAug 03Option Exercise0.001,700021,687Aug 05 05:45 PM
PETERSMEYER GARY SDirectorAug 03Sale37.851,70064,33919,987Aug 05 05:45 PM
Taborga Jorge R.Executive VP. EngineeringJul 29Option Exercise0.0010,023059,096Aug 01 05:34 PM
Taborga Jorge R.Executive VP. EngineeringJul 29Sale40.0010,023400,92049,073Aug 01 05:34 PM
Seim Robin GeneEVP, Global A & M AdherenceJul 06Sale34.755,302184,23950,118Jul 07 02:02 PM
Seim Robin GeneEVP, Global A & M AdherenceJul 01Option Exercise0.003,645059,065Jul 01 05:59 PM
Seim Robin GeneEVP, Global A & M AdherenceJul 01Sale35.003,645127,57555,420Jul 01 05:59 PM